Literature DB >> 8815392

Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease.

M Héroux1, V L Raghavendra Rao, J Lavoie, J S Richardson, R F Butterworth.   

Abstract

There is a growing body of evidence to suggest that thiamine neurochemistry is disrupted in Alzheimer's Disease (AD). Studies in autopsied brain tissue from neuropathologically proven AD patients reveal significantly reduced activities of the thiamine phosphate dephosphorylating enzymes thiamine diphosphatase (TDPase) and thiamine monophosphatase (TMPase) as well as the thiamine diphosphate-dependent enzymes, pyruvate dehydrogenase complex, alpha-ketoglutarate dehydrogenase (alpha KGDH) and transketolase. Reductions in enzyme activities are present both in affected areas of AD brain as well as in relatively well conserved tissue. Decreased TDP concentrations and concomitantly increased TMP in autopsied brain tissue from AD patients and in CSF from patients with Dementia of the Alzheimer Type suggests that CNS thiamine phosphorylation-dephosphorylation mechanisms are disrupted in AD. alpha KGDH is a rate-limiting enzyme for cerebral glucose utilization and decreases in its activity are associated with lactic acidosis, cerebral energy failure and neuronal cell loss. Deficiencies of TDP-related metabolic processes could therefore participate in neuronal cell death mechanisms in AD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815392     DOI: 10.1007/bf02080933

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  33 in total

1.  Possible involvement of thiamine in acetylcholine release.

Authors:  L Eder; L Hirt; Y Dunant
Journal:  Nature       Date:  1976-11-11       Impact factor: 49.962

Review 2.  Thiamine in excitable tissues: reflections on a non-cofactor role.

Authors:  L Bettendorff
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

3.  Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease.

Authors:  R F Butterworth; A M Besnard
Journal:  Metab Brain Dis       Date:  1990-12       Impact factor: 3.584

4.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 1. The pyruvate dehydrogenase complex.

Authors:  R F Butterworth; J F Giguere; A M Besnard
Journal:  Neurochem Res       Date:  1985-10       Impact factor: 3.996

5.  Thiamine and cholinergic transmission in the electric organ of Torpedo. I. Cellular localization and functional changes of thiamine and thiamine phosphate esters.

Authors:  L Eder; Y Dunant
Journal:  J Neurochem       Date:  1980-12       Impact factor: 5.372

6.  Low energy levels in thiamine-deficient encephalopathy.

Authors:  H Aikawa; I S Watanabe; T Furuse; Y Iwasaki; E Satoyoshi; T Sumi; T Moroji
Journal:  J Neuropathol Exp Neurol       Date:  1984-05       Impact factor: 3.685

7.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency.

Authors:  A M Hakim; H M Pappius
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

9.  Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease.

Authors:  V L Rao; J S Richardson; R F Butterworth
Journal:  Brain Res       Date:  1993-12-24       Impact factor: 3.252

10.  Neuronal changes in experimental gliomas.

Authors:  P L Lantos; G J Pilkington
Journal:  Neuropathol Appl Neurobiol       Date:  1980 Jul-Aug       Impact factor: 8.090

View more
  19 in total

1.  Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain.

Authors:  Jing Zhao; Xiaojing Sun; Zhe Yu; Xiaoli Pan; Fenghua Gu; Jia Chen; Wenxin Dong; Lei Zhao; Chunjiu Zhong
Journal:  Neurotox Res       Date:  2010-06-22       Impact factor: 3.911

2.  Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability?

Authors:  L W Ko; K F Sheu; H T Thaler; W R Markesbery; J P Blass
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

3.  The crystal structure of human transketolase and new insights into its mode of action.

Authors:  Lars Mitschke; Christoph Parthier; Kathrin Schröder-Tittmann; Johannes Coy; Stefan Lüdtke; Kai Tittmann
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

4.  Long-Term Cognitive Improvement After Benfotiamine Administration in Patients with Alzheimer's Disease.

Authors:  Xiaoli Pan; Zhichun Chen; Guoqiang Fei; Shumei Pan; Weiqi Bao; Shuhua Ren; Yihui Guan; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2016-10-01       Impact factor: 5.203

Review 5.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

6.  Thiamine status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells.

Authors:  Marjorie Gangolf; Jan Czerniecki; Marc Radermecker; Olivier Detry; Michelle Nisolle; Caroline Jouan; Didier Martin; Frédéric Chantraine; Bernard Lakaye; Pierre Wins; Thierry Grisar; Lucien Bettendorff
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

7.  Thiamine nutritional status and depressive symptoms are inversely associated among older Chinese adults.

Authors:  Geng Zhang; Hanqing Ding; Honglei Chen; Xingwang Ye; Huaixing Li; Xu Lin; Zunji Ke
Journal:  J Nutr       Date:  2012-11-21       Impact factor: 4.798

8.  Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.

Authors:  Victor Tapias; Shari Jainuddin; Manuj Ahuja; Cliona Stack; Ceyhan Elipenahli; Julie Vignisse; Meri Gerges; Natalia Starkova; Hui Xu; Anatoly A Starkov; Lucien Bettendorff; Dmitry M Hushpulian; Natalya A Smirnova; Irina G Gazaryan; Navneet A Kaidery; Sushama Wakade; Noel Y Calingasan; Bobby Thomas; Gary E Gibson; Magali Dumont; M Flint Beal
Journal:  Hum Mol Genet       Date:  2018-08-15       Impact factor: 6.150

9.  A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.

Authors:  Stefan Schneider; Stefan Lüdtke; Kathrin Schröder-Tittmann; Cindy Wechsler; Danilo Meyer; Kai Tittmann
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Thiamine deficiency caused by thiamine antagonists triggers upregulation of apoptosis inducing factor gene expression and leads to caspase 3-mediated apoptosis in neuronally differentiated rat PC-12 cells.

Authors:  Sergiy Chornyy; Julia Parkhomenko; Nataliya Chorna
Journal:  Acta Biochim Pol       Date:  2007-05-15       Impact factor: 2.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.